Can Benadryl (diphenhydramine) cause tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Benadryl (Diphenhydramine) Increase Heart Rate?

Yes, diphenhydramine (Benadryl) can cause tachycardia, particularly in overdose situations, but may also cause this effect at therapeutic doses in some individuals.

Cardiovascular Effects of Diphenhydramine

Diphenhydramine has complex effects on the cardiovascular system that can manifest as changes in heart rate:

Mechanisms of Heart Rate Effects

  • Anticholinergic Properties: Diphenhydramine blocks muscarinic receptors, which can inhibit parasympathetic tone and lead to tachycardia 1
  • Sodium Channel Blockade: At higher doses, diphenhydramine can block sodium channels in cardiac tissue, similar to tricyclic antidepressants, which can affect cardiac conduction 2, 3
  • Biphasic Effect: In some cases, diphenhydramine may initially cause tachycardia followed by bradycardia, particularly in overdose situations 1

Documented Cardiovascular Effects

  • In overdose situations, mean heart rate was found to be 103 ± 25 beats/min, significantly higher than normal 4
  • QTc prolongation has been documented with diphenhydramine use, which averaged 453 ± 43 ms in overdose patients compared to 416 ± 35 ms in controls 4
  • In severe cases, diphenhydramine can cause wide-complex tachycardia requiring intervention 3

Risk Factors for Tachycardia with Diphenhydramine

Certain populations are at higher risk for experiencing tachycardia with diphenhydramine:

  • Pediatric patients: Children may be more sensitive to the cardiovascular effects, with documented cases of cardiac arrest following IV administration 5
  • Elderly patients: Decreased baroreceptor response and age-related changes in drug metabolism can increase sensitivity 1
  • Patients with pre-existing cardiac disease: Underlying cardiac conditions may predispose to arrhythmias 1
  • Concomitant medication use: Combination with other anticholinergic drugs can potentiate tachycardia 1

Clinical Implications

Therapeutic Use Considerations

  • Standard parenteral dosing of diphenhydramine is 25-50 mg IV, which can cause cardiovascular effects even at therapeutic doses 6
  • When used as an adjunct for sedation, diphenhydramine's adverse effects can include hypotension, dizziness, and cardiovascular effects 1

Overdose Management

  • In cases of significant tachycardia or QRS widening, sodium bicarbonate administration may reverse sodium channel blockade 2, 3
  • For severe toxicity with hemodynamic instability, IV lipid emulsion therapy has been used successfully 7
  • ECG monitoring is essential in suspected overdose cases to detect conduction abnormalities 4

Important Caveats

  • While tachycardia is possible with diphenhydramine, individual responses vary considerably
  • The anticholinergic effects of diphenhydramine may mask bradycardia caused by other conditions
  • In some patients, particularly those with underlying heart disease, diphenhydramine may paradoxically cause bradycardia rather than tachycardia
  • The risk of significant cardiovascular effects increases substantially with doses above therapeutic range

In clinical practice, awareness of diphenhydramine's potential to cause tachycardia is important, especially when administering to patients with pre-existing cardiovascular conditions or when combined with other medications that affect heart rate.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Electrocardiogram Abnormalities Following Diphenhydramine Ingestion: A Case Report.

Journal of education & teaching in emergency medicine, 2023

Research

A Case of Massive Diphenhydramine and Naproxen Overdose.

The Journal of emergency medicine, 2021

Research

Cardiac Arrest Following the Administration of Intravenous Diphenhydramine for Sedation to an Infant With Congenital Heart Disease.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2021

Guideline

Migraine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.